Tyrosine kinase inhibitor nilotinib increases atherosclerosis burden in ApoE knock-out mice
Event: ESC Congress 2019
Topic: Leukocytes, Inflammation, Immunity
Session: Vascular remodelling from capillaries to aorta
ESC 365 is supported by
